ABSTRACT
There is growing evidence that oxidative phosphorylation (OXPHOS) generates reactive oxygen and nitrogen species within mitochondria as unwanted byproducts that can damage OXPHOS enzymes with subsequent enhancement of free radical production. The accumulation of this oxidative damage to mitochondria in brain is thought to lead to neuronal cell death resulting in neurodegeneration. The predominant reactive nitrogen species in mitochondria are nitric oxide and peroxynitrite. Here we show that peroxynitrite reacts with mitochondrial membranes from bovine heart to significantly inhibit the activities of complexes I, II and V (50-80%), but with less effect upon complex IV and no significant inhibition of complex III. Since inhibition of complex I activity has been a reported feature of Parkinson's disease, we undertook a detailed analysis of peroxynitrite-induced modifications to proteins from an enriched complex I preparation. Immunological and mass spectrometric approaches coupled with 2D PAGE have been used to show that peroxynitrite modification resulting in a 3-nitrotyrosine signature is predominantly associated with the complex I subunits, 49 kDa subunit (NDUFS2), TYKY (NDUFS8), B17.2 (17.2 kDa differentiation associated protein), B15 (NDUFB4) and B14 (NDUFA6). Nitration sites and estimates of modification yields were deduced from MS/MS fragmentograms and extracted ion chromatograms, respectively for the last 3 of these subunits as well as for 2 co-purifying proteins, the β and the d subunits of the F1FO ATP synthase. Subunits B15 (NDUFB4) and B14 (NDUFA6) contained (2) . Moreover, a 30 % decrease in complex I activity has been detected in studies on post-mortem brain tissue from PD patients (3) , and evidence of complex I subunit depletion has also been reported (4) . The extent of damage to complex I and other key enzymes of energy metabolism that triggers the onset of neurodegeneration and the characteristic symptoms of Parkinson's disease is not known. However, it is pertinent to note that the threshold for complex I activity in brain is the highest of any tissue, such that it requires only a modest degree of inhibition of oxidative phosphorylation to cause cellular dysfunction (5) .
Increasingly, the evidence points to oxidative stress as the major cause of agerelated mitochondrial damage. In line with the free radical hypothesis of neurodegeneration, depletion of glutathione, a critical antioxidant in cellular defenses against free radical damage, has been observed to precede mitochondrial damage and cell apoptosis of the neurons of the substantia nigra in presymptomatic PD patients (6, 7) . In accord with the above studies, glutathione depletion has been found to lead to complex I inhibition and reduced ATP production in a dopaminergic neuronal cell line (8) .
It has been known for 30 years that complexes I, II and III of the respiratory chain produce superoxide (O2 Ÿ -) as an unwanted byproduct of oxidative phosphorylation, when partially reduced electron carriers such as flavins, nonheme iron centers and ubisemiquinone persist long enough to react with molecular oxygen (9, 10) . Peroxynitrite (ONOO -), formed by the reaction of O2
Ÿ -with nitric oxide (NO Ÿ ), is implicated as one of the major oxidants responsible for mitochondrial damage (11) . NO Ÿ , present in mitochondria in around 1 µM amounts (12) , is generated by the mitochondrial nitric oxide synthase (13) (14) (15) , and this second messenger functions as a physiological regulator of the respiratory chain by reversibly binding and inhibiting complex IV (16) . The short-lived but highly reactive ONOO -damages mitochondria by modifying DNA (17), lipids (18) and proteins within the organelle. Protein modification can occur by oxidation to produce for example N-formylkynurenine residues from tryptophans (19) , by nitration of tyrosines to generate 3-nitrotyrosine (3NT) and by S-nitrosylation of cysteines (20) . Recently the formation of 3NT has been observed in the MPTP-induced PD animal model (21, 22) . Further, 3NT α-6 synuclein has been detected in the Lewy body inclusions found in the SN cells of PD patients (23) .
The effect of ONOO -on mitochondrial function has been studied in vitro mainly by exposure of cultured cells to NO Ÿ . Complex I inhibition was observed in all cases but there is no consensus on whether reversible S-nitrosylation via thiols (24) (25) (26) or irreversible inactivation by nitration of tyrosines (27, 28) , or both, is the cause of this inhibition. Here we have used direct addition of ONOO -to examine the oxidative damage induced in beef heart mitochondrial membranes by this reagent.
The effect of exposure to ONOO -was assessed by activity measurements on all of the complexes of the OXPHOS system, and the sites of modification of complex I by the reagent were examined using mass spectrometry. The reactive tyrosines identified here may serve as candidates for early biomarkers of Parkinson's disease.
METHODS
Preparation of bovine and human mitochondria. Bovine heart mitochondria were prepared according to Smith (29 Each sample was used to hydrate 18 cm immobiline pH gradient strips with pH ranges of 3 -10 or 6 -11 (Amersham) for 12 hours. Isoelectric focusing was performed in three stages of applied potential difference; 500 V for 1 hour, 1000
V for 1 hour and 8000 V for up to 10 hours, until 60,000 Vh were achieved.
Focused strips were soaked in SDS-PAGE buffer (50 mM Tris-HCl pH 8.8, 6M
urea, 30 % glycerol, 2 % SDS, 0.01 % bromophenol blue) for 15 min at room temperature and then applied to 15 % acrylamide gels for SDS-PAGE. 2D gels were stained with silver nitrate by the method of Schevchenko et al. (34) .
Immunological detection of proteins containing 3NT. 1D or 2D gels were transferred in CAPS buffer from gels to PVDF membranes (0.45 µm pore size) according to Triepels (35) . Proteins containing 3NT were detected by an anti-3NT polyclonal antibody (Upstate), followed by a secondary goat anti-mouse polyclonal antibody conjugated to alkaline phosphatase (2D) or horseradish peroxidase (1D), then detected by the NBT/BCIP (Biorad) or ECL+ (Amersham) detection methods respectively.
Sample preparation for analysis by mass spectrometry. Gel bands and spots, corresponding to areas of 3NT immunoreactivity on b lots, were manually excised from gels with a razor. Destaining of silver-stained samples and digestions were performed as described previously (36) Dynamic exclusion was employed to select the maximum number of unique peptide peaks from the chromatograms. After replicate MS/MS spectra were acquired for a precursor ion, the m/z value of ion was placed on an exclusion list with a ± 1.5 u window for 1 min. Each chromatogram was subsequently analyzed with the program SEQUEST (40) using either the bovine or human subsets of the nr database (22 Jan, 2003 ) that had been "indexed for speed" with methionine oxidation (+16 u) and either tyrosine nitration (+45) or tryptophan dioxidation (+32) specified as differential modifications using TurboSEQUEST® (ThermoFinnigan) software. The requirement for a protein assignment was at least 1 peptide for a particular protein having an Xcorr > 1.7 for a +1 ion, Xcorr > 2.0 for a +2 ion or Xcorr > 3 for a +3 ion. In all cases ∆corr must be greater than 0.1.
Peptides assigned as being nitrated had to satisfy the following requirements irrespective of their SEQUEST scores based upon a comparison with their unmodified counterparts: [1] they should be more hydrophobic (41) and [2] their MS/MS fragmentograms should be comparable differing mainly by +45 u additions of mass to the corresponding a, y and b series. Requirement [1] was checked by comparing the single ion chromatograms for the peptides (m/z ± 0.5 u) (Figs. 4-6) and requirement [2] was checked by manual inspection of the MS/MS spectra for the unmodified and modified peptides respectively.
Estimates of levels of nitration. Extracted ion LC/MS/MS chromatograms for
nitrated and the corresponding un-nitrated peptides were subjected to 15 point Gaussian smoothing using the Qual Brower program of the Finnigan Xcalibur 1.3 software and integrated after manually choosing peak areas corresponding to the eluting peptides. Comparison of the peak areas of the nitrated versus unnitrated peptides for relative quantitation assumes that the species have identical ionization efficiencies. This assumption was felt to be justified based upon the fact that nitration imparts no additional charge on the peptides, and accounts for a relatively small increase (2-6%) in the peptides' molecular masses.
Furthermore Smallwood et al. (42) have demonstrated that approximate abundances estimated from relative MS currents for a nitrated and un-nitrated 16 residue tryptic peptide from calmodulin were confirmed using absorbance at 381 nm (43) . The latter method is independent of ionization efficiency.
RESULTS

Inhibition of the respiratory chain complexes I-V by ONOO -modification.
Bovine heart mitochondrial preparations were variously incubated with 0, 50, 200, 800, 1600
and 2400 µM ONOO - (Fig. 1A) . When 2400 µM ONOO -was used, disruption of the lipid bilayer was evident from the reduced light scattering of the sample.
Complex I, II and V (the ATP synthase) were each inhibited between 40 and 50%
at 800 µM ONOO -, whereas complex IV was inhibited close to 20% and complex III was unaffected at this reagent concentration. Levels of inhibition were higher for complexes I, II and V at 1600 µM ONOO -, and each of these complexes was fully inhibited at 2400 µM ONOO -. Upon treatment with 2400 µM ONOO -, complex IV activity was only inhibited by 45% whereas complex III activity remained unaffected. In all cases, the activity of complexes III and IV were fully inhibited by their specific inhibitors antimycin A and KCN, respectively. The activity of the mitochondrial matrix enzyme citrate synthase is often used as a marker for mitochondrial integrity. This enzyme was inhibited 29%, 58% and 99% by 800, 1600 and 2400 µM ONOO -. These relative effects of ONOO -upon the activity of OXPHOS complexes I-IV observed here are consistent with those found for rat brain mitochondria by Brookes and co-workers using 200 µM ONOO - (44) . In summary, complexes I, II and V activities are each sensitive to ONOO -reaction while complexes III and IV are much less inhibited or unaffected by the reagent. As a negative control, the addition of 800 µM degraded ONOO -had no effect upon the activity of any of the enzymes measured.
ONOO -reaction of complex I involves mainly 3NT formation. There are several potential reaction mechanisms for inhibition of complex I by peroxynitrite including nitration of tyrosine (forming 3NT) and S-nitrosylation of cysteine residues. The extent of S-nitrosylation can be evaluated because the reaction is reversible in the presence of reducing agents such as glutathione or dithiothreitol (DTT). As shown in Fig. 1B , addition of 1 mM and 10 mM DTT after ONOOtreatment of mitochondria failed to restore activity. This suggests that Snitrosylation of cysteine residues is not a major cause of ONOO --induced inhibition of complex I under our reaction conditions. Further, prior incubation of the membranes with DTT, followed by 800 µM ONOO -had no effect upon activity. All of these activities were greater than 99% repressed by the competitive inhibitor rotenone. These 3NT-modified proteins in fraction 2 were better resolved by 2D PAGE using an isoelectric focusing step from pH 3-10. Eight 3NT-positive spots could now be observed because the 22 kDa band in the 1D gel was resolved into two distinct spots (labeled spot 2 and spot c, see Fig. 3A ). Finally, for better separation of spots 3, 4 and 5, isoelectric focusing was carried out using pH 7-11 strip (Fig 3B &C) . Superimposing the gels for excising proteins with the companion Western blot can be difficult because the two are subject to different staining and destaining conditions which lead to different swelling of gels versus blots. To circumvent this problem, the position of the 15 kDa subunit (NDUFS5), a well defined protein for which we have a specific, high affinity monoclonal antibody, was used as a landmark to correlate the two gel patterns. On this basis, we were able to make an initial identification of the 3NT-modified subunits 
Isolation of complex I and identification of subunits incorporating
Identification of specific tyrosines modified by ONOO -.
Tyrosines modified by nitration were identified in LC/MS/MS experiments by fragment mass shifts of +45 Da. (Table II) . Four individual 3NT-modified tyrosines were found in subunit B15 at residues Y 46 , Y 50 , Y 51 and the C terminal residue Y 128 ; the first 3 of these are in the same peptide but only one of the 3 was modified in any peptide copy. It was estimated that 19% of the copies of this B15 peptide were nitrated, based on measurement of the area under the peak of single ion chromatograms (Fig. 4) . Also nitrated was the C-terminal peptide of subunit B14 at residue Y 122 . For this peptide, the yield was difficult to quantify because of co-eluting species in the same m/z range as the nitrated species.
Though the calculated yield of 69% may be somewhat over-estimated, it was clearly evident that the relative proportion of un-nitrated peptide was low ( (Fig. 6 ). Table II Such findings have led to the proposition that complex I damage by low levels of toxins, in combination with free radical damage as discussed above, are the cause of a significant proportion of cases of late onset Parkinson's disease (1) . To test this premise, it is necessary to identify readily measured biomarkers that report accumulated free radical-mediated damage of the complex. The observation of 3NT-modified proteins in brain (22, 23) indicates that one of the major free radicals reacting is ONOO -produced by mitochondria, and here we have sought to identify the effect of this short-lived species on the activity of the entire respiratory chain and ATP synthase, as well as its sites of modification. Focusing on complex I, we have used mass spectrometry to identify sites of relatively heavy modification.
ONOO -reacts predominately with tyrosines and cysteines in proteins (50, 51) .
We determined that the reagent causes high levels of inhibition of complex I and also complex II and ATP synthase. ONOO -exposure has a partial inhibitory effect on complex IV and little effect upon complex III. As each of these complexes contain many tyrosines and cysteines, the activity effects must be related to both reactivity of individual tyrosines or cysteines and the role that these amino acid residues play in enzyme function. In the case of complex I, our data indicate that irreversible inhibitory effects may be due to reaction with tyrosines rather than cysteine residues. Though complex I is composed of [45] [46] different subunits that together contain more than 300 tyrosine residues in bovine and human (36,52), we found 3NT modifications of tyrosine to be associated with only 5 subunits. These polypeptides were the 49 kDa, TYKY, B17.2, B15 and B14 subunits, which together contain 41 tyrosine residues. Two of these subunits, the 49 kDa and TYKY, contain prosthetic groups and/or have been shown to be involved in the enzyme's function (53) . However, by Western analysis, the observed levels of modification of these two subunits together are low and cannot account for the loss of function. The three proteins containing higher levels of 3NT modification are B17.2, B15 and B14. The B17.2 subunit is also known as DAP for its similarity to a 13 kDa differentiation associationlinked protein (54) , but the implication of this similarity and its function in complex I is not understood. This subunit is not heavily modified, but rather most of the observed 3NT incorporation is in tyrosine residues in subunit B15
and B14, two subunits for which there are no known functions at present. Both are present in subcomplex 1α as defined by Walker and colleagues, with B15 also present in subcomplex 1β, the membrane domain (55) .
Mass spectrometric analysis of B15 and B14 identified one peptide in each subunit having high levels of 3NT incorporation. For the peptide fragment 45 EYQLQYYDPSR 55 in B15, 19% of the sequence contained the 3NT modification.
Interestingly, close analysis revealed individual modification of each of the three tyrosines in the fragment, but no evidence of dual or triple 3NT modification. A fourth tyrosine Y 128 was also identified as a modification site in subunit B15, but to a lesser degree of susceptibility to nitration. Only o ne tyrosine of the identified peptides of subunit B14 contained 3NT, Y 122 , and our results suggest that it may be the most heavily modified tyrosine residue analyzed. The mass spectrometric analysis also detected sites of 3NT modification in B17.2 as well as the β and d subunits of ATP synthase, but the extent of this modification at any tyrosine was in each case less than 10%. Since peptide coverage of all the subunits examined above was incomplete, other tyrosines not examined by the analysis could be modified as well. Nevertheless, it is already clear that the number of tyrosines reactive to ONOO -is relatively small, and that no one or two are responsible for irreversible complex I inhibition.
In this study we have also observed the double oxidation of a tryptophan residue in subunit B17.2 resulting in the formation of N-formylkynurenine, as well as oxidation of methionine, in the tryptic peptide WVITYYEMNGK. In previous work we identified other complex I subunits from human heart mitochondria in which tryptophan is oxidized including: 75 kDa (NDUFS1), 51 kDa (V1), 39 kDa (A9), 30 kDa (S3), 18 kDa (S4), ESSS (NP17.3), B13 (A5), PSST (S7), and TYKY (S8) (19) by searching our extensive mitoproteome database of over 800,000 MS/MS spectra (56) using the SONAR MS/MS algorithm (57) . Given the results herein, we reanalyzed LC/MS/MS of human samples in our database in which the homologue of B17.2 was identified using the complementary SEQUEST algorithm (40) and found that the homologous peptide WVVYTTEMNGK was identically modified at both tryptophan and methionine residues (Xcorr =2.67, ∆corr = 0.46 for a +2 ion) indicating that we have found another "hot spot" of oxidative stress in respiring mitochondria (19) . However, given the presence of tryptophan oxidation in untreated mitochondria, the modification cannot be unequivocally associated with peroxynitrite-induced oxidative stress. In contrast, to date we have not found any of the nitrated peptides reported herein, or their human homologues in untreated mitochondria. This result may simply reflect that the nitrated peptides were present at levels below our detection limits. Alternatively, the result is consistent with the lack of 3NT-immunoreactivity in gel bands from bovine mitochondria prior to the ONOOreaction supporting our conclusion that 3NT, unlike N-formylkynurenine, is not a feature of normal cardiac mitochondria.
In summary our studies have discovered several sites of modification of complex I that result from ONOO -exposure. We envision that such a molecular modification may contribute to the altered functioning of the complex and play a key role in the onset of Parkinson's disease. Two sites were identified in which the post-translational modification of tyrosine to 3NT was particularly extensive.
We suggest that several of these sites, such as residues 45-55, containing a cluster of tyrosine residues in B15 and the peptide containing Y 122 in subunit B14, may have diagnostic utility in assessing free radical damage related to Parkinson's disease and other human degenerative disorders caused by oxidative stress, and in animal models of these diseases. 
